Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/90287/1/phco.20.12.152S.35254.pd
The antiepileptic efficacy and tolerability of oxcarbazepine, used both as monotherapy and adjunctiv...
CONTEXT AND OBJECTIVE: It has been estimated that 50 million people worldwide suffer from epilepsy a...
SummaryPurposeTo evaluate the long-term efficacy, tolerability, and safety of oxcarbazepine (OXC) in...
Oxcarbazepine is approved as monotherapy and adjunctive therapy for partial seizures with and withou...
Purpose: To evaluate the long-term efficacy, tolerability, and safety of oxcarbazepine (OXC) in medi...
In this study, oxcarbazepine was began as monotherapy to evaluate the efficacy and safety of the dru...
In this study, oxcarbazepine was began as monotherapy to evaluate the efficacy and safety of the dru...
SummaryThe antiepileptic efficacy and tolerability of oxcarbazepine, used both as monotherapy and ad...
Almost 50 million people in the world, a third of whom children, suffer from epilepsy. Up to 30 % of...
WOS: 000181959800006PubMed ID: 12657418In this study, oxcarbazepine was began as monotherapy to eval...
Objective1-3% of the population suffer from epilepsy. Up to 30% of them develop refractory epilepsy ...
Objective: Carbamazepine (CBZ) is a first-choice antiepileptic agent used primarily for partial seiz...
Objective 1-3 of the population suffer from epilepsy. Up to 30 of them develop refractory epilepsy a...
none8PURPOSE: To evaluate the long-term efficacy, tolerability, and safety of oxcarbazepine (OXC) in...
Background Partial onset seizures are often treated with the standard antiepileptic drug carbamazepi...
The antiepileptic efficacy and tolerability of oxcarbazepine, used both as monotherapy and adjunctiv...
CONTEXT AND OBJECTIVE: It has been estimated that 50 million people worldwide suffer from epilepsy a...
SummaryPurposeTo evaluate the long-term efficacy, tolerability, and safety of oxcarbazepine (OXC) in...
Oxcarbazepine is approved as monotherapy and adjunctive therapy for partial seizures with and withou...
Purpose: To evaluate the long-term efficacy, tolerability, and safety of oxcarbazepine (OXC) in medi...
In this study, oxcarbazepine was began as monotherapy to evaluate the efficacy and safety of the dru...
In this study, oxcarbazepine was began as monotherapy to evaluate the efficacy and safety of the dru...
SummaryThe antiepileptic efficacy and tolerability of oxcarbazepine, used both as monotherapy and ad...
Almost 50 million people in the world, a third of whom children, suffer from epilepsy. Up to 30 % of...
WOS: 000181959800006PubMed ID: 12657418In this study, oxcarbazepine was began as monotherapy to eval...
Objective1-3% of the population suffer from epilepsy. Up to 30% of them develop refractory epilepsy ...
Objective: Carbamazepine (CBZ) is a first-choice antiepileptic agent used primarily for partial seiz...
Objective 1-3 of the population suffer from epilepsy. Up to 30 of them develop refractory epilepsy a...
none8PURPOSE: To evaluate the long-term efficacy, tolerability, and safety of oxcarbazepine (OXC) in...
Background Partial onset seizures are often treated with the standard antiepileptic drug carbamazepi...
The antiepileptic efficacy and tolerability of oxcarbazepine, used both as monotherapy and adjunctiv...
CONTEXT AND OBJECTIVE: It has been estimated that 50 million people worldwide suffer from epilepsy a...
SummaryPurposeTo evaluate the long-term efficacy, tolerability, and safety of oxcarbazepine (OXC) in...
DOI
Add to ORKG